Gene · 948
Papers3,971
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 3,971
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Research Progress on Glycoprotein 5 of Porcine Reproductive and Respiratory Syndrome Virus. | Animals (Basel) | 2023 | 36899670 | PubTator, text mining | PubMed |
| Sub-gingival delivery of simvastatin and rosuvastatin for treatment of chronic periodontitis with diabetes mellitus: A randomized controlled clinical-radiographic pilot study. | J Oral Biol Craniofac Res | 2023 | 36891284 | PubTator, text mining | PubMed |
| Autophagy: A Cellular Guardian against Hepatic Lipotoxicity. | Genes (Basel) | 2023 | 36874473 | PubTator, text mining | PubMed |
| Blood transcriptome responses to PFOA and GenX treatment in the marsupial biomedical model Monodelphis domestica. | Front Genet | 2023 | 36873954 | PubTator, text mining | PubMed |
| Bacteriophage P22 Capsid as a Pluripotent Nanotechnology Tool. | Viruses | 2023 | 36851730 | PubTator, text mining | PubMed |
| Special Issue "State-of-the-Art Porcine Virus Research in China". | Viruses | 2023 | 36851626 | PubTator, text mining | PubMed |
| Development and acceptance of a new adherence monitoring package to identify non-adherent patients with polypharmacy in primary care: a feasibility study. | BMJ Open Qual | 2023 | 36849193 | PubTator, text mining | PubMed |
| Infection dynamics, transmission, and evolution after an outbreak of porcine reproductive and respiratory syndrome virus. | Front Microbiol | 2023 | 36846785 | PubTator, text mining | PubMed |
| Structural and Molecular Basis for Mitochondrial DNA Replication and Transcription in Health and Antiviral Drug Toxicity. | Molecules | 2023 | 36838782 | PubTator, text mining | PubMed |
| Pre-Diabetes-Linked miRNA miR-193b-3p Targets PPARGC1A, Disrupts Metabolic Gene Expression Profile and Increases Lipid Accumulation in Hepatocytes: Relevance for MAFLD. | Int J Mol Sci | 2023 | 36835287 | PubTator, text mining | PubMed |
| Anti-Atherogenic Actions of the Lab4b Consortium of Probiotics In Vitro. | Int J Mol Sci | 2023 | 36835055 | PubTator, text mining | PubMed |
| Microbe-Derived Antioxidants Alleviate Liver and Adipose Tissue Lipid Disorders and Metabolic Inflammation Induced by High Fat Diet in Mice. | Int J Mol Sci | 2023 | 36834674 | PubTator, text mining | PubMed |
| Lipidomic and Proteomic Profiling of the Milk Fat Globule Membrane from Different Industrial By-Products of the Butter and Butter Oil Manufacturing Process. | Foods | 2023 | 36832824 | PubTator, text mining | PubMed |
| Interactions between Platelets and Tumor Microenvironment Components in Ovarian Cancer and Their Implications for Treatment and Clinical Outcomes. | Cancers (Basel) | 2023 | 36831623 | PubTator, text mining | PubMed |
| Peripheral Immunophenotype in IgG4-Related Disease and Its Association with Clinical Phenotypes and Disease Activity. | Cells | 2023 | 36831337 | PubTator, text mining | PubMed |
| Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies. | Biomedicines | 2023 | 36831004 | PubTator, text mining | PubMed |
| IgG N-Glycosylation Is Altered in Coronary Artery Disease. | Biomolecules | 2023 | 36830744 | PubTator, text mining | PubMed |
| Ganglioside GM3 prevents high fat diet-induced hepatosteatosis via attenuated insulin signaling pathway. | PLoS One | 2023 | 36827398 | PubTator, text mining | PubMed |
| Acquired disorders of mitochondrial metabolism and dynamics in pulmonary arterial hypertension. | Front Cell Dev Biol | 2023 | 36819102 | PubTator, text mining | PubMed |
| Targeting immuno-oncology metabolism for precision cancer therapy. | Front Oncol | 2023 | 36816957 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/948/papers?page=23